| 1 |
32021384 | The Effect of UGT1A9, CYP2B6 and CYP2C9 Genes Polymorphism on Propofol Pharmacokinetics in Children. | 2020 |
3 |
| 2 |
33816071 | Influence of Potential Gene Polymorphisms on Propofol Dosage Regimen in Patients Undergoing Abdominal Hysterectomy. | 2020 Nov |
2 |
| 3 |
29468507 | Impact of clinical factors and UGT1A9 and CYP2B6 genotype on inter-individual differences in propofol pharmacokinetics. | 2018 Apr |
2 |
| 4 |
32025958 | Effect of sex and polymorphisms of CYP2B6 and UGT1A9 on the difference between the target-controlled infusion predicted and measured plasma propofol concentration. | 2018 Aug 13 |
2 |
| 5 |
27826892 | The effect of UGT1A9, CYP2B6 and CYP2C9 genes polymorphism on individual differences in propofol pharmacokinetics among Polish patients undergoing general anaesthesia. | 2017 May |
2 |
| 6 |
28154789 | CYP2B6 Genotype Guided Dosing of Propofol Anesthesia in the Elderly based on Nonparametric Population Pharmacokinetic Modeling and Simulations. | 2017 |
4 |
| 7 |
29133890 | Longrange PCR-based next-generation sequencing in pharmacokinetics and pharmacodynamics study of propofol among patients under general anaesthesia. | 2017 Nov 13 |
2 |
| 8 |
26141406 | Impact of the Cytochrome P450 2B6 (CYP2B6) Gene Polymorphism c.516G>T (rs3745274) on Propofol Dose Variability. | 2016 Oct |
6 |
| 9 |
27362518 | Pharmacogenetics of Anesthesia: An Integrative Review. | 2016 Jul-Aug |
2 |
| 10 |
27709010 | Insights into CYP2B6-mediated drug-drug interactions. | 2016 Sep |
1 |
| 11 |
27749294 | A Case of Delayed Emergence After Propofol Anesthesia: Genetic Analysis. | 2016 Dec 1 |
3 |
| 12 |
26307675 | Application of HC-AFW1 Hepatocarcinoma Cells for Mechanistic Studies: Regulation of Cytochrome P450 2B6 Expression by Dimethyl Sulfoxide and Early Growth Response 1. | 2015 Nov |
1 |
| 13 |
24153159 | Association of the CYP2B6 c.516G>T polymorphism with high blood propofol concentrations in women from northern Greece. | 2014 |
2 |
| 14 |
23640947 | The impact of genetic factors on response to anaesthetics. | 2013 |
1 |
| 15 |
21301907 | Analysis of clinically relevant substrates of CYP2B6 enzyme by computational methods. | 2011 Nov |
4 |
| 16 |
21869535 | Individual differences in pharmacokinetics and pharmacodynamics of anesthetic agent propofol with regard to CYP2B6 and UGT1A9 genotype and patient age. | 2011 |
5 |
| 17 |
19442086 | Polymorphic drug metabolism in anaesthesia. | 2009 Mar |
1 |
| 18 |
19702527 | Substrate specificity, regulation, and polymorphism of human cytochrome P450 2B6. | 2009 Sep |
1 |
| 19 |
18781911 | CYP2B6: new insights into a historically overlooked cytochrome P450 isozyme. | 2008 Sep |
1 |
| 20 |
17620218 | Involvement of human cytochrome P450 2B6 in the omega- and 4-hydroxylation of the anesthetic agent propofol. | 2007 Jul |
9 |
| 21 |
17073575 | The functional role of CYP2B6 in human drug metabolism: substrates and inhibitors in vitro, in vivo and in silico. | 2006 Oct |
1 |
| 22 |
17101742 | Evaluation of 227 drugs for in vitro inhibition of cytochrome P450 2B6. | 2006 Dec |
2 |
| 23 |
11135730 | Cytochrome P-450 2B6 is responsible for interindividual variability of propofol hydroxylation by human liver microsomes. | 2001 Jan |
5 |
| 24 |
11298076 | Involvement of human liver cytochrome P4502B6 in the metabolism of propofol. | 2001 Mar |
5 |